Skip to main content
SpringerLink
Log in

Pathology of Germ Cell Tumors

  • Chapter
  • First Online:
Diagnostic Pathology of Ovarian Tumors

Abstract

This chapter familiarizes the reader with the various germ cell tumors: malignant germ cell tumors (dysgerminoma, embryonal carcinoma, yolk sac tumor, polyembryoma, choriocarcinoma), benign germ cell tumors (teratomas, carcinoid tumors), malignant mixed germ cell tumors, and gonadoblastoma. The clinical features, macroscopic features, microscopic immunohistochemistry, and differential diagnoses of these tumor types are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roth LM, Talerman A. Recent advances in the pathology and classification of ovarian germ cell tumors. Int J Gynecol Pathol. 2006;25(4):305–20.

    Article  PubMed  Google Scholar 

  2. Smith HO, Berwick M, Verschraegen CF, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075–85.

    Article  PubMed  Google Scholar 

  3. Lee KH, Lee IH, Kim BG, et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean gynecologic oncology group study. Int J Gynecol Cancer. 2009;19(1):84–7.

    Article  PubMed  Google Scholar 

  4. Asadourian LA, Taylor HB. Dysgerminoma. An analysis of 105 cases. Obstet Gynecol. 1969;33:370–9.

    PubMed  CAS  Google Scholar 

  5. Bjorkholm E, Lundell M, Gyftodimos A, Silfversward C. Dysgerminoma. The radiumhemmet series 1927–1984. Cancer. 1990;65:38–44.

    Article  PubMed  CAS  Google Scholar 

  6. Gordon A, Lipton D, Woodruff JD. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol. 1981;58:497–504.

    PubMed  CAS  Google Scholar 

  7. Buller RE, Darrow V, Manetta A, Porto M, DiSaia PJ. Conservative surgical management of dysgerminoma concomitant with pregnancy. Obstet Gynecol. 1992;79(5 pt 2):887–90.

    PubMed  CAS  Google Scholar 

  8. Masahito H, Hara F, Tomishige H, et al. 1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma. Pediatr Hematol Oncol. 2008;25(1):73–8.

    Article  PubMed  CAS  Google Scholar 

  9. Inoue H, Kikuchi Y, Hirata J, Wada S, Seki K, Nagata I. Dysgerminoma of the ovary with hypercalcemia associated with elevated parathyroid hormone-related protein. Jpn J Clin Oncol. 1995;25:113–7.

    PubMed  CAS  Google Scholar 

  10. Zaloudek CJ, Tavassoli FA, Norris HJ. Dysgerminoma with syncytiotrophoblastic giant cells: a histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol. 1981;5:361–7.

    Article  PubMed  CAS  Google Scholar 

  11. Kumar S, Shah JP, Bryant CS, et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol. 2008;110(2):125–32.

    Article  PubMed  Google Scholar 

  12. Chan JK, Tewari KS, Waller S, et al. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008;98(2):111–6.

    Article  PubMed  Google Scholar 

  13. Patterson DM, Murugaesu N, Holden L, Seckl MJ, Rustin GJ. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer. 2008;18(1):43–50.

    Article  PubMed  CAS  Google Scholar 

  14. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25(20):2938–43.

    Article  PubMed  CAS  Google Scholar 

  15. Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev. 2008;34(5):427–41.

    Article  PubMed  CAS  Google Scholar 

  16. Dietl J, Horny HP, Ruck P, Kaiserling E. Dysgerminoma of the ovary: an immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells. Cancer. 1993;71:2562–8.

    Article  PubMed  CAS  Google Scholar 

  17. Stewart CJR, Farquharson MA, Foulis AK. Characterization of the inflammatory infiltrate in ovarian dysgerminoma: an immunocytochemical study. Histopathology. 1992;20:491–7.

    Article  PubMed  CAS  Google Scholar 

  18. Chang MC, Vargas SO, Hornick JL, Hirsch MS, Crum CP, Nucci MR. Embryonic stem cell transcription factors and D2-40 (Podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol. 2009;28(4):347–55. 310.1097/PGP.

    Article  PubMed  CAS  Google Scholar 

  19. Sever M, Jones TD, Roth LM, et al. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications. Mod Pathol. 2005;18(11):1411–6.

    Article  PubMed  CAS  Google Scholar 

  20. Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009;33(6):894–904.

    Article  PubMed  Google Scholar 

  21. Hoei-Hansen CE, Kraggerud SM, Abeler VM, Kaern J, Rajpert-De Meyts E, Lothe RA. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer. 2007;6:12.

    Article  PubMed  CAS  Google Scholar 

  22. Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol. 2004;28(10):1341–6.

    Article  PubMed  Google Scholar 

  23. Cossu-Rocca P, Jones TD, Roth LM, et al. Cytokeratin and CD30 expression in dysgerminoma. Hum Pathol. 2006;37(8):1015–21.

    Article  PubMed  CAS  Google Scholar 

  24. Kurman RJ, Norris HJ. Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer. 1976;38:2420–33.

    Article  PubMed  CAS  Google Scholar 

  25. Kammerer-Doak D, Baurick K, Black W, Barbo DM, Smith HO. Endodermal sinus tumor and embryonal carcinoma of the ovary in a 53-year-old woman. Gynecol Oncol. 1996;63:133–7.

    Article  PubMed  CAS  Google Scholar 

  26. Cheng L, Zhang S, Talerman A, Roth LM. Morphologic, immuno­histochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma. Hum Pathol. 2010;41(5):716–23.

    Article  PubMed  CAS  Google Scholar 

  27. Esheba GE, Pate LL, Longacre TA. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Am J Surg Pathol. 2008;32(4):600–7.

    Article  PubMed  Google Scholar 

  28. Damjanov I, Osborn M, Miettinen M. Keratin 7 is a marker for a subset of trophoblastic cells in human germ cell tumors. Arch Pathol Lab Med. 1990;114(1):81–3.

    PubMed  CAS  Google Scholar 

  29. Kurman RJ, Norris HJ. Malignant germ cell tumors of the ovary. Hum Pathol. 1977;8:551–64.

    Article  PubMed  CAS  Google Scholar 

  30. Kawai M, Kano T, Kikkawa F, et al. Seven tumor markers in benign and malignant germ cell tumors of the ovary. Gynecol Oncol. 1992;45:248–53.

    Article  PubMed  CAS  Google Scholar 

  31. Dallenbach P, Bonnefoi H, Pelte MF, Vlastos G. Yolk sac tumours of the ovary: an update. Eur J Surg Oncol. 2006;32(10):1063–75.

    PubMed  CAS  Google Scholar 

  32. Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary. A clinical and pathologic analysis of 71 cases. Cancer. 1976;38:2404–19.

    Article  PubMed  CAS  Google Scholar 

  33. Gershenson DM, del Junco G, Herson J, Rutledge FN. Endodermal sinus tumor of the ovary: the M.D. Anderson experience. Obstet Gynecol. 1983;61:194–202.

    PubMed  CAS  Google Scholar 

  34. de La Motte Rouge T, Pautier P, Duvillard P, et al. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol. 2008;19(8):1435–41.

    Article  Google Scholar 

  35. Kang H, Kim TJ, Kim WY, et al. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol. 2008;111(1):106–10.

    Article  PubMed  CAS  Google Scholar 

  36. Shah JP, Kumar S, Bryant CS, et al. A population-based analysis of 788 cases of yolk sac tumors: a comparison of males and females. Int J Cancer. 2008;123(11):2671–5.

    Article  PubMed  CAS  Google Scholar 

  37. Clement PB, Young RH, Scully RE. Endometrioid-like variant of ovarian yolk sac tumor. A clinicopathological analysis of eight cases. Am J Surg Pathol. 1987;11:767–78.

    Article  PubMed  CAS  Google Scholar 

  38. Nogales FF, Matilla A, Nogales-Ortiz F, Galera-Davidson H. Yolk sac tumors with pure and mixed polyvesicular vitelline patterns. Hum Pathol. 1978;9:553–66.

    Article  PubMed  Google Scholar 

  39. Nakashima N, Fukatsu T, Nagasaka T, Sobue M, Takeuchi J. The frequency and histology of hepatic tissue in germ cell tumors. Am J Surg Pathol. 1987;11:682–92.

    Article  PubMed  CAS  Google Scholar 

  40. Ulbright TM, Roth LM, Brodhecker CA. Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features. Am J Surg Pathol. 1986;10:151–64.

    Article  PubMed  CAS  Google Scholar 

  41. Prat J, Bhan AK, Dickersin GR, Robboy SJ, Scully RE. Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer. 1982;50:2355–68.

    Article  PubMed  CAS  Google Scholar 

  42. Devouassoux-Shisheboran M, Schammel DP, Tavassoli FA. Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural features. Histopathology. 1999;34(5):462–9.

    Article  PubMed  CAS  Google Scholar 

  43. Pitman MB, Triratanachat S, Young RH, Oliva E. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Int J Gynecol Pathol. 2004;23(1):58–64.

    PubMed  Google Scholar 

  44. Michael H, Ulbright TM, Brodhecker CA. The pluripotential nature of the mesenchyme-like component of yolk sac tumor. Arch Pathol Lab Med. 1989;113:1115–9.

    PubMed  CAS  Google Scholar 

  45. Nogales FF, Buritica C, Regauer S, Gonzalez T. Mucinous carcinoid as an unusual manifestation of endodermal differentiation in ovarian yolk sac tumors. Am J Surg Pathol. 2005;29(9):1247–51.

    Article  PubMed  Google Scholar 

  46. Rutgers JL, Young RH, Scully RE. Ovarian yolk sac tumor arising from an endometrioid carcinoma. Hum Pathol. 1987;18:1296–9.

    Article  PubMed  CAS  Google Scholar 

  47. Nogales FF, Bergeron C, Carvia RE, Alvaro T, Fulwood HR. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm - analysis of six cases. Am J Surg Pathol. 1996;20(9):1056–66.

    Article  PubMed  CAS  Google Scholar 

  48. Lopez JM, Malpica A, Deavers MT, Ayala AG. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary. Ann Diagn Pathol. 2003;7(5):300–5.

    Article  PubMed  Google Scholar 

  49. Ramalingam P, Malpica A, Silva EG, Gershenson DM, Liu JL, Deavers MT. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004;28(11):1499–505.

    Article  PubMed  Google Scholar 

  50. Maeda D, Ota S, Takazawa Y, et al. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol. 2009;22(6):824–32.

    PubMed  CAS  Google Scholar 

  51. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol. 1984;8:575–96.

    Article  PubMed  CAS  Google Scholar 

  52. Zaloudek CJ, Norris HJ. Granulosa tumors of the ovary in children: a clinical and pathologic study of 32 cases. Am J Surg Pathol. 1982;6:503–12.

    Article  PubMed  CAS  Google Scholar 

  53. Ishikura H, Scully RE. Hepatoid carcinoma of the ovary. A newly described tumor. Cancer. 1987;60:2775–84.

    Article  PubMed  CAS  Google Scholar 

  54. Yigit S, Uyaroglu MA, Kus Z, Ekinci N, Oztekin O, Yigit S, et al. Hepatoid carcinoma of the ovary: immunohistochemical finding of one case and literature review. Int J Gynecol Cancer. 2006;16(3):1439–41.

    Article  PubMed  CAS  Google Scholar 

  55. Tochigi N, Kishimoto T, Supriatna Y, Nagai Y, Nikaido T, Ishikura H. Hepatoid carcinoma of the ovary: a report of three cases admixed with a common surface epithelial carcinoma. Int J Gynecol Pathol. 2003;22(3):266–71.

    Article  PubMed  Google Scholar 

  56. Jondle DM, Shahin MS, Sorosky J, Benda JA. Ovarian mixed germ cell tumor with predominance of polyembryoma: a case report with literature review. Int J Gynecol Pathol. 2002;21(1):78–81.

    Article  PubMed  Google Scholar 

  57. Takemori M, Nishimura R, Yamasaki M, Kawabe Y, Hasegawa K. Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma. Gynecol Oncol. 1998;69:260–3.

    Article  PubMed  CAS  Google Scholar 

  58. King ME, Hubbell MJ, Talerman A. Mixed germ cell tumor of the ovary with a prominent polyembryoma component. Int J Gynecol Pathol. 1991;10:88–95.

    Article  PubMed  CAS  Google Scholar 

  59. Koo HL, Choi J, Kim KR, Kim JH. Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis. Pathol Int. 2006;56(10):613–6.

    Article  PubMed  Google Scholar 

  60. Goswami D, Sharma K, Zutshi V, Tempe A, Nigam S. Nongestational pure ovarian choriocarcinoma with contralateral teratoma. Gynecol Oncol. 2001;80(2):262–6.

    Article  PubMed  CAS  Google Scholar 

  61. Tsujioka H, Hamada H, Miyakawa T, Hachisuga T, Kawarabayashi T. A pure nongestational choriocarcinoma of the ovary diagnosed with DNA polymorphism analysis. Gynecol Oncol. 2003;89(3):540–2.

    Article  PubMed  Google Scholar 

  62. Park SH, Park A, Kim JY, Kwon JH, Koh SB. A case of non-gestational choriocarcinoma arising in the ovary of a postmenopausal woman. J Gynecol Oncol. 2009;20(3):192–4.

    Article  PubMed  Google Scholar 

  63. Axe SR, Klein VR, Woodruff JD. Choriocarcinoma of the ovary. Obstet Gynecol. 1985;66:111–4.

    PubMed  CAS  Google Scholar 

  64. Balat O, Kutlar I, Ozkur A, Bakir K, Aksoy F, Ugur MG. Primary pure ovarian choriocarcinoma mimicking ectopic pregnancy: a report of fulminant progression. Tumori. 2004;90(1):136–8.

    PubMed  Google Scholar 

  65. Fisher RA, Newlands ES, Jeffreys AJ, et al. Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer. 1992;69:839–45.

    Article  PubMed  CAS  Google Scholar 

  66. Yamamoto E, Ino K, Yamamoto T, et al. A pure nongestational choriocarcinoma of the ovary diagnosed with short tandem repeat analysis: case report and review of the literature. Int J Gynecol Cancer. 2007;17(1):254–8.

    Article  PubMed  CAS  Google Scholar 

  67. Daya D, Sabet L. The use of cytokeratin as a sensitive and reliable marker for trophoblastic tissue. Am J Clin Pathol. 1991;95(2):137–41.

    PubMed  CAS  Google Scholar 

  68. Shih IM, Kurman RJ. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol. 1999;18(2):144–50.

    Article  PubMed  CAS  Google Scholar 

  69. Ordi J, Romagosa C, Tavassoli FA, et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol. 2003;27(2):178–86.

    Article  PubMed  Google Scholar 

  70. Gershenson DM, del Junco G, Copeland LJ, Rutledge FN. Mixed germ cell tumors of the ovary. Obstet Gynecol. 1984;64:200–7.

    PubMed  CAS  Google Scholar 

  71. Kurman RJ, Norris HJ. Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases. Obstet Gynecol. 1976;48:579–89.

    PubMed  CAS  Google Scholar 

  72. Oliva E, Andrada E, Pezzica E, Prat J. Ovarian carcinomas with choriocarcinomatous differentiation. Cancer. 1993;72:2441–6.

    Article  PubMed  CAS  Google Scholar 

  73. Cho NH, Kim YT, Lee JH, et al. Diagnostic challenge of fetal ontogeny and its application on the ovarian teratomas. Int J Gynecol Pathol. 2005;24(2):173–82.

    Article  PubMed  Google Scholar 

  74. Koonings PP, Campbell K, Mishell Jr DR, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol. 1989;74:921–6.

    PubMed  CAS  Google Scholar 

  75. Comerci Jr JT, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol. 1994;84:22–8.

    PubMed  Google Scholar 

  76. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091–8.

    Article  PubMed  CAS  Google Scholar 

  77. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25–36.

    Article  PubMed  CAS  Google Scholar 

  78. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11–8.

    Article  PubMed  Google Scholar 

  79. Sabin TD, Jednacz JA, Staats PN. Case records of the Massachusetts General Hospital. Case 26–2008. A 26-year-old woman with headache and behavioral changes. N Engl J Med. 2008;359(8):842–53.

    Article  PubMed  CAS  Google Scholar 

  80. Robboy SJ, Scully RE. Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases. Hum Pathol. 1970;1:643–53.

    Article  PubMed  CAS  Google Scholar 

  81. Nielsen SN, Scheithauer BW, Gaffey TA. Gliomatosis peritonei. Cancer. 1985;56(10):2499–503.

    Article  PubMed  CAS  Google Scholar 

  82. Steeper TA, Mukai K. Solid ovarian teratomas: an immunocytochemical study of thirteen cases with clinicopathologic correlation. Pathol Annu. 1984;19:81–92.

    PubMed  Google Scholar 

  83. Russell P, Painter DM. The pathological assessment of ovarian neoplasms. V. The germ cell tumours. Pathology. 1982;14:47–72.

    Article  PubMed  CAS  Google Scholar 

  84. Nogales FF, Vergara E, Medina MT. Prostate in ovarian mature cystic teratoma. Histopathology. 1995;26:373–5.

    Article  PubMed  CAS  Google Scholar 

  85. Halabi M, Oliva E, Mazal PR, Breitenecker G, Young RH. Prostatic tissue in mature cystic teratomas of the ovary: a report of four cases, including one with features of prostatic adenocarcinoma, and cytogenetic studies. Int J Gynecol Pathol. 2002;21(3):261–7.

    Article  PubMed  Google Scholar 

  86. Stamp GW, McConnell EM. Malignancy arising in cystic ovarian teratomas. A report of 24 cases. Br J Obstet Gynaecol. 1983;90:671–5.

    Article  PubMed  CAS  Google Scholar 

  87. Hirakawa T, Tsuneyoshi M, Enjoji M. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Clinicopathologic and topographic analysis. Am J Surg Pathol. 1989;13:397–405.

    Article  PubMed  CAS  Google Scholar 

  88. Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Munstedt K. Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data. Lancet Oncol. 2008;9(12):1173–80.

    Article  PubMed  Google Scholar 

  89. Ribeiro G, Hughesdon P, Wiltshaw E. Squamous carcinoma arising in dermoid cysts and associated with hypercalcemia: a clinicopathologic study of six cases. Gynecol Oncol. 1988;29:222–30.

    Article  PubMed  CAS  Google Scholar 

  90. Tseng CJ, Chou HH, Huang KG, et al. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Gynecol Oncol. 1996;63:364–70.

    Article  PubMed  CAS  Google Scholar 

  91. Kikkawa F, Ishikawa H, Tamakoshi K, Nawa A, Suganuma N, Tomoda Y. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis. Obstet Gynecol. 1997;89(6):1017–22.

    Article  PubMed  CAS  Google Scholar 

  92. Baker PM, Rosai J, Young RH. Ovarian teratomas with florid benign vascular proliferation: a distinctive finding associated with the neural component of teratomas that may be confused with a vascular neoplasm. Int J Gynecol Pathol. 2002;21(1):16–21.

    Article  PubMed  Google Scholar 

  93. Pins MR, Young RH, Daly WJ, Scully RE. Primary squamous cell carcinoma of the ovary. Report of 37 cases. Am J Surg Pathol. 1996;20:823–33.

    Article  PubMed  CAS  Google Scholar 

  94. Tobon H, Surti U, Naus GJ, Hoffner L, Hemphill RW. Squamous cell carcinoma in situ arising in an ovarian mature cystic teratoma. Report of one case with histopathologic, cytogenetic, and flow cytometric DNA content analysis. Arch Pathol Lab Med. 1991;115:172–4.

    PubMed  CAS  Google Scholar 

  95. Monteagudo C, Torres JV, Llombart-Bosch A. Extramammary Paget’s disease arising in a mature cystic teratoma of the ovary. Histopathology. 1999;35(6):582–4.

    Article  PubMed  CAS  Google Scholar 

  96. Vartanian RK, McRae B, Hessler RB. Sebaceous carcinoma arising in a mature cystic teratoma of the ovary. Int J Gynecol Pathol. 2002;21(4):418–21.

    Article  PubMed  Google Scholar 

  97. Davis GL. Malignant melanoma arising in mature ovarian cystic teratoma (dermoid cyst). Report of two cases and literature analysis. Int J Gynecol Pathol. 1996;15:356–62.

    Article  PubMed  CAS  Google Scholar 

  98. Gupta D, Deavers MT, Silva EG, Malpica A. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases. Am J Surg Pathol. 2004;28(6):771–80.

    Article  PubMed  Google Scholar 

  99. McCluggage WG, Bissonnette JP, Young RH. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms. Int J Gynecol Pathol. 2006;25(4):321–9.

    Article  PubMed  Google Scholar 

  100. Kushima M. Adenocarcinoma arising from mature cystic teratoma of the ovary. Pathol Int. 2004;54(2):139–43.

    Article  PubMed  Google Scholar 

  101. Contreras AL, Malpica A. Angiosarcoma arising in mature cystic teratoma of the ovary: a case report and review of the literature. Int J Gynecol Pathol. 2009;28(5):453–7.

    Article  PubMed  Google Scholar 

  102. Vang R, Gown AM, Zhao C, et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol. 2007;31(6):854–69.

    Article  PubMed  Google Scholar 

  103. McKenney JK, Soslow RA, Longacre TA. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol. 2008;32(5):645–55.

    Article  PubMed  Google Scholar 

  104. Ronnett BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol. 2003;27(5):650–7.

    Article  PubMed  Google Scholar 

  105. Hwang JH, So K-A, Modi G, et al. Borderline-like mucinous tumor arising in mature cystic teratoma of the ovary associated with pseudomyxoma peritonei. Int J Gynecol Pathol. 2009;28(4):376–80.

    Article  PubMed  Google Scholar 

  106. Marquette S, Amant F, Vergote I, Moerman P. Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report. Int J Gynecol Pathol. 2006;25(4):340–3.

    Article  PubMed  Google Scholar 

  107. Stewart CJ, Tsukamoto T, Cooke B, Leung YC, Hammond IG. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour. Pathology. 2006;38(6):534–8.

    Article  PubMed  CAS  Google Scholar 

  108. Gershenson DM. Malignant germ-cell tumors of the ovary. Clin Obstet Gynecol. 1985;28(4):824–38.

    Article  PubMed  CAS  Google Scholar 

  109. Bonazzi C, Peccatori F, Colombo N, Lucchini V, Cantó MG, Mangioni C. Pure ovarian immature teratoma, a unique and curable disease: 10 years’ experience of 32 prospectively treated patients. Obstet Gynecol. 1994;84:598–604.

    PubMed  CAS  Google Scholar 

  110. Poulos C, Cheng L, Zhang S, Gersell DJ, Ulbright TM. Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements. Mod Pathol. 2006;19(6):766–71.

    PubMed  CAS  Google Scholar 

  111. Kraggerud SM, Szymanska J, Abeler VM, et al. DNA copy number changes in malignant ovarian germ cell tumors. Cancer Res. 2000;60(11):3025–30.

    PubMed  CAS  Google Scholar 

  112. Baker BA, Frickey L, Yu IT, Hawkins EP, Cushing B, Perlman EJ. DNA content of ovarian immature teratomas and malignant germ cell tumors. Gynecol Oncol. 1998;71:14–8.

    Article  PubMed  CAS  Google Scholar 

  113. Kildal W, Kaern J, Kraggerud SM, et al. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors–relation to clinicopathologic variables. Cancer Genet Cytogenet. 2004;155(1):25–32.

    Article  PubMed  CAS  Google Scholar 

  114. Rodriguez E, Melamed J, Reuter V, Chaganti RS. Chromosome 12 abnormalities in malignant ovarian germ cell tumors. Cancer Genet Cytogenet. 1995;82:62–6.

    Article  PubMed  CAS  Google Scholar 

  115. Doss BJ, Jacques SM, Qureshi F, et al. Immature teratomas of the genital tract in older women. Gynecol Oncol. 1999;73(3):433–8.

    Article  PubMed  CAS  Google Scholar 

  116. van Altena AM, Wijnberg GJ, Kolwijck E, De Hullu JA, Massuger LF. A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitis. Gynecol Oncol. 2008;108(2):445–8.

    Article  PubMed  Google Scholar 

  117. de Lins e Horta H, de Castro AF, Fonseca RP, Fernandes Jr AS, Lima VS, Neuenschwander LC. Limbic encephalitis associated with immature teratoma. Eur J Gynaecol Oncol. 2009;30(3):329–31.

    PubMed  Google Scholar 

  118. Marina NM, Cushing B, Giller R, et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. J Clin Oncol. 1999;17(7):2137–43.

    PubMed  CAS  Google Scholar 

  119. Beiner ME, Gotlieb WH, Korach Y, et al. Cystectomy for immature teratoma of the ovary. Gynecol Oncol. 2004;93(2):381–4.

    Article  PubMed  Google Scholar 

  120. Low JJH, Perrin LC, Crandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors – a review of 74 cases. Cancer. 2000;89(2):391–8.

    Article  PubMed  CAS  Google Scholar 

  121. Lu KH, Gershenson DM. Update on the management of ovarian germ cell tumors. J Reprod Med. 2005;50(6):417–25.

    PubMed  Google Scholar 

  122. Heifetz SA, Cushing B, Giller R, et al. Immature teratomas in children: pathologic considerations – a report from the combined Pediatric Oncology Group Children’s Cancer Group. Am J Surg Pathol. 1998;22(9):1115–24.

    Article  PubMed  CAS  Google Scholar 

  123. Mann JR, Gray ES, Thornton C, et al. Mature and immature extracranial teratomas in children: the UK Children’s Cancer Study Group Experience. J Clin Oncol. 2008;26(21):3590–7.

    Article  PubMed  Google Scholar 

  124. Li H, Hong W, Zhang R, Wu L, Liu L, Zhang W. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma. Chin Med J (Engl). 2002;115(10):1496–500.

    Google Scholar 

  125. Hariprasad R, Kumar L, Janga D, Kumar S, Vijayaraghavan M. Growing teratoma syndrome of ovary. Int J Clin Oncol. 2008;13(1):83–7.

    Article  PubMed  Google Scholar 

  126. Zagame L, Pautier P, Duvillard P, Castaigne D, Patte C, Lhomme C. Growing teratoma syndrome after ovarian germ cell tumors. Obstet Gynecol. 2006;108(3):509–14.

    Article  PubMed  Google Scholar 

  127. Mengshol SC, DeMars LR, Schned AR. Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst. Gynecol Oncol. 2004;92(1):353–6.

    Article  PubMed  Google Scholar 

  128. Dadmanesh F, Miller DM, Swenerton KD, Clement PB. Gliomatosis peritonei with malignant transformation. Mod Pathol. 1997;10:597–601.

    PubMed  CAS  Google Scholar 

  129. Shefren G, Collin J, Soriero O. Gliomatosis peritonei with malignant transformation: a case report and review of the literature. Am J Obstet Gynecol. 1991;164:1617–20; discussion 1620.

    PubMed  CAS  Google Scholar 

  130. Yanai-Inbar I, Scully RE. Relation of ovarian dermoid cysts and immature teratomas: an analysis of 350 cases of immature teratoma and 10 cases of dermoid cyst with microscopic foci of immature tissue. Int J Gynecol Pathol. 1987;6:203–12.

    Article  PubMed  CAS  Google Scholar 

  131. Nogales FF, Favera BE, Major FJ, Silverberg SG. Immature teratoma of the ovary with a neural component (“solid” teratoma). A clinicopathologic study of 20 cases. Hum Pathol. 1976;7:625–42.

    Article  PubMed  Google Scholar 

  132. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases. Cancer. 1976;37:2359–72.

    Article  PubMed  CAS  Google Scholar 

  133. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18 Suppl 2:S61–79.

    Article  PubMed  Google Scholar 

  134. Vance RP, Geisinger KR, Randall MB, Marshall RB. Immature neural elements in immature teratomas. An immunohistochemical and ultrastructural study. Am J Clin Pathol. 1988;90:397–411.

    PubMed  CAS  Google Scholar 

  135. Nogales FF, Avila IR, Concha A, Del Moral E. Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry. Hum Pathol. 1993;24:364–70.

    Article  PubMed  CAS  Google Scholar 

  136. Nogales FF, Ortega I, Rivera F, Armas JR. Metanephrogenic tissue in immature ovarian teratoma. Am J Surg Pathol. 1980;4:297–9.

    Article  PubMed  Google Scholar 

  137. O’Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol. 1994;13:283–9.

    Article  PubMed  Google Scholar 

  138. Harms D, Janig U, Gîbel U. Gliomatosis peritonei in childhood and adolescence. Clinicopathological study of 13 cases including immunohistochemical findings. Pathol Res Pract. 1989;184:422–30.

    PubMed  CAS  Google Scholar 

  139. Nogales FF, Aguilar D. Florid vascular proliferation in grade 0 glial implants from ovarian immature teratoma. Int J Gynecol Pathol. 2002;21(3):305–7.

    PubMed  Google Scholar 

  140. Calder CJ, Light AM, Rollason TP. Immature ovarian teratoma with mature peritoneal metastatic deposits showing glial, epithelial, and endometrioid differentiation: a case report and review of the literature. Int J Gynecol Pathol. 1994;13:279–82.

    Article  PubMed  CAS  Google Scholar 

  141. Dworak O, Knopfle G, Varchmin-Schultheiss K, Meyer G. Gliomatosis peritonei with endometriosis externa. Gynecol Oncol. 1988;29:263–6.

    Article  PubMed  CAS  Google Scholar 

  142. Ferguson AW, Katabuchi H, Ronnett BM, Cho KR. Glial implants in gliomatosis peritonei arise from normal tissue, not from the associated teratoma. Am J Pathol. 2001;159(1):51–5.

    Article  PubMed  CAS  Google Scholar 

  143. Kwan MY, Kalle W, Lau GT, Chan JK. Is gliomatosis peritonei derived from the associated ovarian teratoma? Hum Pathol. 2004;35(6):685–8.

    Article  PubMed  Google Scholar 

  144. Best DH, Butz GM, Moller K, Coleman WB, Thomas DB. Molecular analysis of an immature ovarian teratoma with gliomatosis peritonei and recurrence suggests genetic independence of multiple tumors. Int J Oncol. 2004;25(1):17–25.

    PubMed  CAS  Google Scholar 

  145. Roth LM. Recent advances in the pathology and classification of ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2006;25(3):199–215.

    Article  PubMed  Google Scholar 

  146. Bing Z, Pasha TL, Lal P, Tomaszewski JE. Expression of glial cell line-derived neurotropic factor receptor alpha-1 in immature teratomas. Am J Clin Pathol. 2008;130(6):892–6.

    Article  PubMed  Google Scholar 

  147. Calame JJ, Schaberg A. Solid teratomas and mixed Mullerian tumors of the ovary: a clinical, histological, and immunocytochemical comparative study. Gynecol Oncol. 1989;33:212–21.

    Article  PubMed  CAS  Google Scholar 

  148. Perrone T, Steeper TA, Dehner LP. Alpha-fetoprotein localization in pure ovarian teratoma. An immunohistochemical study of 12 cases. Am J Clin Pathol. 1987;88:713–7.

    PubMed  CAS  Google Scholar 

  149. Zynger DL, Everton MJ, Dimov ND, Chou PM, Yang XJ. Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol. 2008;130(2):224–30.

    Article  PubMed  Google Scholar 

  150. Michael H, Hull MT, Ulbright TM, Foster RS, Miller KD. Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol. 1997;21:896–904.

    Article  PubMed  CAS  Google Scholar 

  151. Kleinman GM, Young RH, Scully RE. Primary neuroectodermal tumors of the ovary: a report of 25 cases. Am J Surg Pathol. 1993;17:764–78.

    Article  PubMed  CAS  Google Scholar 

  152. Kawauchi S, Fukuda T, Miyamoto S, et al. Peripheral primitive neuroectodermal tumor of the ovary confirmed by CD99 immunostaining, karyotypic analysis, and RT-PCR for EWS/FLI-1 chimeric mRNA. Am J Surg Pathol. 1998;22:1417–22.

    Article  PubMed  CAS  Google Scholar 

  153. Young RH, Kozakewich HPW, Scully RE. Metastatic ovarian tumors in children: a report of 14 cases and review of the literature. Int J Gynecol Pathol. 1993;12:8–19.

    Article  PubMed  CAS  Google Scholar 

  154. McCluggage WG. Ovarian neoplasms composed of small round cells: a review. Adv Anat Pathol. 2004;11(6):288–96.

    Article  PubMed  Google Scholar 

  155. Guerrieri C, Jarlsfelt I. Ependymoma of the ovary: a case report with immunohistochemical, ultrastructural, and DNA cytometric findings, as well as histogenetic considerations. Am J Surg Pathol. 1993;17:623–32.

    Article  PubMed  CAS  Google Scholar 

  156. Idowu MO, Rosenblum MK, Wei XJ, Edgar MA, Soslow RA. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct – a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein. Am J Surg Pathol. 2008;32(5):710–8.

    Article  PubMed  Google Scholar 

  157. Carr KA, Roberts JA, Frank TS. Progesterone receptors in bilateral ovarian ependymoma presenting in pregnancy. Hum Pathol. 1992;23:962–5.

    Article  PubMed  CAS  Google Scholar 

  158. Opris I, Ducrotoy V, Bossut J, Lamy A, Sabourin J-C. Oligodendroglioma arising in an ovarian mature cystic teratoma. Int J Gynecol Pathol. 2009;28(4):367–71.

    Article  PubMed  Google Scholar 

  159. Hirahara F, Yamanaka M, Miyagia E, et al. Pure ovarian ependymoma: report of a case treated with surgery, chemotherapy, irradiation and hyperthermotherapy. Eur J Obstet Gynecol Reprod Biol. 1997;75(2):221–3.

    Article  PubMed  CAS  Google Scholar 

  160. Roth LM, Talerman A. The enigma of struma ovarii. Pathology. 2007;39(1):139–46.

    Article  PubMed  Google Scholar 

  161. Robboy SJ, Shaco-Levy R, Peng RY, et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol. 2009;28(5):405–22.

    Article  PubMed  Google Scholar 

  162. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 1993;12:333–43.

    Article  PubMed  CAS  Google Scholar 

  163. Shaco-Levy R, Bean SM, Bentley RC, Robboy SJ. Natural history of biologically malignant struma ovarii: analysis of 27 cases with extraovarian spread. Int J Gynecol Pathol. 2010;29(3):212–27. 210.1097/PGP.1090b1013e3181bfb1133.

    Article  PubMed  Google Scholar 

  164. Garg K, Soslow RA, Rivera M, Tuttle MR, Ghossein RA. Histologically bland “extremely well differentiated” thyroid carcinomas arising in struma ovarii can recur and metastasize. Int J Gynecol Pathol. 2009;28(3):222–30.

    Article  PubMed  Google Scholar 

  165. Logani S, Baloch ZW, Snyder PJ, Weinstein R, Livolsi VA. Cystic ovarian metastasis from papillary thyroid carcinoma: a case report. Thyroid. 2001;11(11):1073–5.

    Article  PubMed  CAS  Google Scholar 

  166. Young RH, Jackson A, Wells M. Ovarian metastasis from thyroid carcinoma 12 years after partial thyroidectomy mimicking struma ovarii: report of a case. Int J Gynecol Pathol. 1994;13:181–5.

    Article  PubMed  CAS  Google Scholar 

  167. DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol. 2003;89(3):543–8.

    Article  PubMed  Google Scholar 

  168. Szyfelbein WM, Young RH, Scully RE. Cystic struma ovarii: A frequently unrecognized tumor: A report of 20 cases. Am J Surg Pathol. 1994;18:785–8.

    Article  PubMed  CAS  Google Scholar 

  169. Szyfelbein WM, Young RH, Scully RE. Struma ovarii simulating ovarian tumors of other types. A report of 30 cases. Am J Surg Pathol. 1995;19:21–9.

    Article  PubMed  CAS  Google Scholar 

  170. Zhang X, Axiotis C. Thyroid-type carcinoma of struma ovarii. Arch Pathol Lab Med. 2010;134(5):786–91.

    PubMed  Google Scholar 

  171. Pelosi G, Sonzogni A, Rosai J. Thyroid-type papillary microcarcinoma in ovarian strumal carcinoid. Int J Surg Pathol. 2008;16(4):435–7.

    Article  PubMed  Google Scholar 

  172. Roth LM, Miller III AW, Talerman A. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature. Int J Gynecol Pathol. 2008;27(4):496–506.

    Article  PubMed  Google Scholar 

  173. Roth LM, Karseladze AI. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis. Int J Gynecol Pathol. 2008;27(2):213–22.

    PubMed  Google Scholar 

  174. Hamazaki S, Okino T, Tsukayama C, Okada S. Expression of thyroid transcription factor-1 in strumal carcinoid and struma ovarii: an immunohistochemical study. Pathol Int. 2002;52(7):458–62.

    Article  PubMed  CAS  Google Scholar 

  175. Boutross-Tadross O, Saleh R, Asa SL. Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol. 2007;18(3):182–6; Fall.

    Article  PubMed  Google Scholar 

  176. Elisei R, Romei C, Castagna MG, et al. RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration. Thyroid. 2005;15(12):1355–61.

    Article  PubMed  CAS  Google Scholar 

  177. Flavin R, Smyth P, Crotty P, et al. BRAF T1799A mutation occurring in a case of malignant struma ovarii. Int J Surg Pathol. 2007;15(2):116–20.

    Article  PubMed  CAS  Google Scholar 

  178. Schmidt J, Derr V, Heinrich MC, et al. BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Surg Pathol. 2007;31(9):1337–43.

    Article  PubMed  Google Scholar 

  179. Celestino R, Magalhaes J, Castro P, et al. A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology. 2009;55(4):482–7.

    Article  PubMed  Google Scholar 

  180. Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases. J Exp Clin Cancer Res. 2000;19(3):271–80.

    PubMed  CAS  Google Scholar 

  181. Young RH, Prat J, Scully RE. Ovarian Sertoli-Leydig cell tumors with heterologous elements. I. Gastrointestinal epithelium and carcinoid: A clinicopathologic analysis of 36 cases. Cancer. 1982;50:2448–56.

    Article  PubMed  CAS  Google Scholar 

  182. Robboy SJ, Scully RE, Norris HJ. Primary trabecular carcinoid of the ovary. Obstet Gynecol. 1977;49:202–7.

    PubMed  CAS  Google Scholar 

  183. Robboy SJ. Insular carcinoid of ovary associated with malignant mucinous tumors. Cancer. 1984;54:2273–6.

    Article  PubMed  CAS  Google Scholar 

  184. Strosberg J, Nasir A, Cragun J, Gardner N, Kvols L. Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases. Gynecol Oncol. 2007;106(1):65–8.

    Article  PubMed  Google Scholar 

  185. Robboy SJ, Scully RE, Norris HJ. Carcinoid metastatic to the ovary. A clinicopathologic analysis of 35 cases. Cancer. 1974;33:798–811.

    Article  PubMed  CAS  Google Scholar 

  186. Davis KP, Hartmann LK, Keeney GL, Shapiro H. Primary ovarian carcinoid tumors. Gynecol Oncol. 1996;61:259–65.

    Article  PubMed  CAS  Google Scholar 

  187. Robboy SJ, Norris HJ, Scully RE. Insular carcinoid primary in the ovary. A clinicopathologic analysis of 48 cases. Cancer. 1975;36:404–18.

    Article  PubMed  CAS  Google Scholar 

  188. Chaowalit N, Connolly HM, Schaff HV, Webb MJ, Pellikka PA. Carcinoid heart disease associated with primary ovarian carcinoid tumor. Am J Cardiol. 2004;93(10):1314–5.

    Article  PubMed  Google Scholar 

  189. Yaegashi N, Tsuiki A, Shimizu T, et al. Ovarian carcinoid with severe constipation due to peptide YY production. Gynecol Oncol. 1995;56:302–6.

    Article  PubMed  CAS  Google Scholar 

  190. Shigeta H, Taga M, Kurogi K, Kitamura H, Motoyama T, Gorai I. Ovarian strumal carcinoid with severe constipation: Immuno­histochemical and mRNA analyses of peptide YY. Hum Pathol. 1999;30(2):242–6.

    Article  PubMed  CAS  Google Scholar 

  191. Matsuda K, Maehama T, Kanazawa K. Strumal carcinoid tumor of the ovary: a case exhibiting severe constipation associated with PYY. Gynecol Oncol. 2002;87(1):143–5.

    Article  PubMed  Google Scholar 

  192. Robboy SJ, Scully RE. Strumal carcinoid of the ovary. An analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer. 1980;46:2019–34.

    Article  PubMed  CAS  Google Scholar 

  193. Wilkowske MA, Hartmann LC, Mullany CJ, Behrenbeck T, Kvols LK. Progressive carcinoid heart disease after resection of primary ovarian carcinoid. Cancer. 1994;73:1889–91.

    Article  PubMed  CAS  Google Scholar 

  194. Armes JE, Ostor AG. A case of malignant strumal carcinoid. Gynecol Oncol. 1993;51:419–23.

    Article  PubMed  CAS  Google Scholar 

  195. Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Am J Clin Pathol. 2001;115(Suppl):S94–112.

    PubMed  Google Scholar 

  196. Talerman A, Evans MI. Primary trabecular carcinoid tumor of the ovary. Cancer. 1982;50:1403–7.

    Article  PubMed  CAS  Google Scholar 

  197. Snyder RR, Tavassoli FA. Ovarian strumal carcinoid: immunohistochemical, ultrastructural, and clinicopathologic analysis. Int J Gynecol Pathol. 1986;5:187–201.

    Article  PubMed  CAS  Google Scholar 

  198. Baker PM, Oliva E, Young RH, Talerman A, Scully RE. Ovarian mucinous carcinoids including some with a carcinomatous component - a report of 17 cases. Am J Surg Pathol. 2001;25(5):557–68.

    Article  PubMed  CAS  Google Scholar 

  199. Stagno PA, Petras RE, Hart WR. Strumal carcinoids of the ovary. An immunohistologic and ultrastructural study. Arch Pathol Lab Med. 1987;111:440–6.

    PubMed  CAS  Google Scholar 

  200. Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol. 2009;28(1):41–8.

    Article  PubMed  Google Scholar 

  201. Sidhu J, Sanchez RL. Prostatic acid phosphatase in strumal carcinoids of the ovary: an immunohistochemical study. Cancer. 1993;72:1673–8.

    Article  PubMed  CAS  Google Scholar 

  202. Sporrong B, Falkmer S, Robboy SJ, et al. Neurohormonal peptides in ovarian carcinoids: an immunohistochemical study of 81 primary carcinoids and of intraovarian metastases from six mid-gut carcinoids. Cancer. 1982;49:68–74.

    Article  PubMed  CAS  Google Scholar 

  203. Hristov AC, Young RH, Vang R, Yemelyanova AV, Seidman JD, Ronnett BM. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases. Am J Surg Pathol. 2007;31(10):1502–11.

    Article  PubMed  Google Scholar 

  204. Tewari K, Cappuccini F, DiSaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000;95(1):128–33.

    Article  PubMed  CAS  Google Scholar 

  205. Talerman A, Roth LM. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives. Int J Gynecol Pathol. 2007;26(3):313–21.

    Article  PubMed  Google Scholar 

  206. Scully RE. Gonadoblastoma: a review of 74 cases. Cancer. 1970;25:1340–56.

    Article  PubMed  CAS  Google Scholar 

  207. Pena-Alonso R, Nieto K, Alvarez R, et al. Distribution of Y-chromosome-bearing cells in gonadoblastoma and dysgenetic testis in 45,X/46,XY infants. Mod Pathol. 2005;18(3):439–45.

    Article  PubMed  CAS  Google Scholar 

  208. Hoepffner W, Horn LC, Simon E, et al. Gonadoblastomas in 5 patients with 46,XY gonadal dysgenesis. Exp Clin Endocrinol Diabetes. 2005;113(4):231–5.

    Article  PubMed  CAS  Google Scholar 

  209. Kim KR, Kwon Y, Joung JY, Kim KS, Ayala AG, Ro JY. True hermaphroditism and mixed gonadal dysgenesis in young children: a clinicopathologic study of 10 cases. Mod Pathol. 2002;15(10):1013–9.

    Article  PubMed  Google Scholar 

  210. Mancilla EE, Poggi H, Repetto G, et al. Y chromosome sequences in Turner’s syndrome: association with virilization and gonadoblastoma. J Pediatr Endocrinol Metab. 2003;16(8):1157–63.

    Article  PubMed  CAS  Google Scholar 

  211. Bianco B, Lipay Mn, Guedes A, Oliveira K, Verreschi ITN. SRY gene increases the risk of developing gonadoblastoma and/or nontumoral gonadal lesions in turner syndrome. Int J Gynecol Pathol. 2009;28(2):197–202. 110.

    Article  PubMed  Google Scholar 

  212. Brant WO, Rajimwale A, Lovell MA, et al. Gonadoblastoma and Turner syndrome. J Urol. 2006;175(5):1858–60.

    Article  PubMed  Google Scholar 

  213. Salo P, Kaariainen H, Petrovic V, Peltomaki P, Page DC, de la Chapelle A. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosom Cancer. 1995;14:210–4.

    Article  PubMed  CAS  Google Scholar 

  214. Lau YF, Li Y, Kido T. Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res C Embryo Today. 2009;87(1):114–22.

    Article  PubMed  CAS  Google Scholar 

  215. Cools M, Stoop H, Kersemaekers AM, et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab. 2006;91(6):2404–13.

    Article  PubMed  CAS  Google Scholar 

  216. Woodcock AS, Govan AD, Gowing NF, Langley FA, Anderson MC. A report of the histological features in 12 cases of gonadoblastoma. Tumori. 1979;65:181–9.

    PubMed  CAS  Google Scholar 

  217. Kersemaekers AM, Honecker F, Stoop H, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol. 2005;36(5):512–21.

    Article  PubMed  CAS  Google Scholar 

  218. Li Y, Vilain E, Conte F, Rajpert-De Meyts E, Lau YF. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Urol Oncol. 2007;25(2):141–6.

    Article  PubMed  CAS  Google Scholar 

  219. Hussong J, Crussi FG, Chou PM. Gonadoblastoma: immunohistochemical localization of Mullerian-inhibiting substance, inhibin, WT-1, and p53. Mod Pathol. 1997;10:1101–5.

    PubMed  CAS  Google Scholar 

  220. Cooper C, Cooper M, Carter J, Russell P. Gonadoblastoma progressing to dysgerminoma in a 55-year-old woman with normal karyotype. Pathology. 2007;39(2):284–5.

    Article  PubMed  Google Scholar 

  221. Susman M, Cooper C, Cooper M, Carter J, Russell P. Gonadoblastoma progressing to dysgerminoma in a 55-year-old woman with normal karyotype: follow-up studies. Pathology. 2008;40(6):645–6.

    Article  PubMed  Google Scholar 

  222. Hertel JD, Huettner PC, Dehner LP, Pfeifer JD. The chromosome Y-linked testis-specific protein locus TSPY1 is characteristically present in gonadoblastoma. Hum Pathol. 2010;41(11):1544–9.

    Article  PubMed  CAS  Google Scholar 

  223. Su MT, Lee IW, Kuo PL. Presence of TSPY transcript and absence of transcripts of other Y chromosomal genes in a case of microscopic gonadoblastoma. Gynecol Oncol. 2006;103(1):357–60.

    Article  PubMed  Google Scholar 

  224. Cossu-Rocca P, Zhang S, Roth LM, et al. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis. Mod Pathol. 2006;19(4):611–5.

    Article  PubMed  CAS  Google Scholar 

  225. Talerman A. A distinctive gonadal neoplasm related to gonadoblastoma. Cancer. 1972;30:1219–24.

    Article  PubMed  CAS  Google Scholar 

  226. Zuntova A, Motlik K, Horejsi J, Eckschlager T. Mixed germ cell-sex cord stromal tumor with heterologous structures. Int J Gynecol Pathol. 1992;11:227–33.

    Article  PubMed  CAS  Google Scholar 

  227. Tokuoka S, Aoki Y, Hayashi Y, Yokoyama T, Ishii T. A mixed germ cell-sex cord-stromal tumor of the ovary with retiform tubular structure: a case report. Int J Gynecol Pathol. 1985;4(2):161–70.

    Article  PubMed  CAS  Google Scholar 

  228. Michal M, Vanecek T, Sima R, et al. Mixed germ cell sex cord-stromal tumors of the testis and ovary. Morphological, immunohistochemical, and molecular genetic study of seven cases. Virchows Arch. 2006;448(5):612–22.

    Article  PubMed  Google Scholar 

  229. Manivel JC, Dehner LP, Burke B. Ovarian tumorlike structures, biovular follicles, and binucleated oocytes in children: their frequency and possible pathologic significance. Pediatr Pathol. 1988;8:283–92.

    Article  PubMed  CAS  Google Scholar 

  230. Safneck JR, de Sa DJ. Structures mimicking sex cord-stromal tumours and gonadoblastomas in the ovaries of normal infants and children. Histopathology. 1986;10:909–20.

    Article  PubMed  CAS  Google Scholar 

  231. Young RH, Welch WR, Dickersin GR, Scully RE. Ovarian sex cord tumor with annular tubules. Review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer. 1982;50:1384–402.

    Article  PubMed  CAS  Google Scholar 

  232. Kandil DH, Cooper K. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more. Adv Anat Pathol. 2009;16(2):125–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of California San Francisco, San Francisco, CA, USA

    Charles J. Zaloudek M.D.

Authors
  1. Charles J. Zaloudek M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Pathology, Memorial Sloan-Kettering Cancer Center, York Ave. 1275, NEW YORK, 10021, New York, USA

    Robert A. Soslow

  2. SUNY Stony Brook, Department of Pathology, Stony Brook Univ Medical Center, Hospital Level 2, Room 766, Stony Brook, 11794-7025, New York, USA

    Carmen Tornos

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Zaloudek, C.J. (2011). Pathology of Germ Cell Tumors. In: Soslow, R., Tornos, C. (eds) Diagnostic Pathology of Ovarian Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9751-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9751-7_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9750-0

  • Online ISBN: 978-1-4419-9751-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation